NEWS・COLUMN
We send the latest information from SMC Laboratories.
A Preclinical Package to Maximize the Value of Your MASH Candidate
Featured in Frontiers in Immunology: A Preclinical Package to Maximize the Value of Your MASH Candidate We are excited to share that a study for which we conducted the preclinical efficacy pharmacology has been published in the journal, Frontiers in Immunology. The paper features the novel MASH drug candidate, “OATD-01,” from our client, Molecure…